Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
accredited, adhere, amplified, analyst, buy, buying, confidence, Cosmetic, discourage, explaining, harder, institutional, NERV, Notwithstanding, refundable, Refusal, registered, registration, RTF, slowdown, small, suitability, symbol, terminated, user, waiver
Removed:
agreed, April, baseline, bioequivalence, closely, conducted, controlled, deducting, dose, economy, efficacy, endpoint, evaluate, evidence, feedback, final, mg, moderate, monotherapy, nominal, pivotal, placebo, population, primary, readily, relapse, specifically, stated, statistically, suffered, symptom
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view